• 1. Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
SHI Yujun, Email: shiyujun@scu.edu.cn
Export PDF Favorites Scan Get Citation

Cancer is a heterogeneous disease characterized by maladjustment of cell death. The types of cell death were mainly divided into two forms including accidental cell death and regulated cell death (RCD). In recent years, researchers have discovered dozens of RCD modes, among which apoptosis, pyroptosis, necroptosis, and ferroptosis are the most widely studied. Cuproptosis is a new cell death mechanism that first proposed on 17 March 2022. It is recognized as a unique and both copper and mitochondria dependent RCD. The research and development of targeted drugs for regulating different cell death pathways will be hots and difficulties in the treatment of refractory cancer in the future.

Citation: GONG Linjing, SHI Yujun. Progress and prospects: regulated cell death in cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2022, 29(5): 582-584. doi: 10.7507/1007-9424.202203088 Copy

  • Previous Article

    Short-term outcome of ascending aorta replacement combined with total aortic arch fenestration technique for acute type A aortic dissection
  • Next Article

    Study on effect of DNA cross-link repair gene DCLRE1B on invasion and migration of hepatocellular carcinoma cells